-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.25

Benzinga·04/08/2026 09:56:49
Listen to the news
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5 to $5.25.